Skip to main content
. 2012 Jan 5;175(4):348–358. doi: 10.1093/aje/kwr292

Table 1.

Comparison of Self-Reported Acetaminophen and Ibuprofen Use With Detection of Acetaminophen and/or Ibuprofen Metabolites in Urine Specimens of Belfast and Chicago Participants, by Gender and Age, International Study of Macro-/Micro-Nutrients and Blood Pressure, 1996–1999

Concordance of Urinary and Self-Report Data Location, Gender, and Age Group, years
Belfast, Northern Ireland (n = 216)
Chicago, Illinois (n = 280)
Men (n = 125)
Women (n = 91)
Subtotal (n = 216)
Men (n = 138)
Women (n = 142)
Subtotal (n = 280)
40–49 (n = 59)
50–59 (n = 66)
40–49 (n = 59)
50–59 (n = 32)
40–49 (n = 59)
50–59 (n = 66)
50–59 (n = 32)
50–59 (n = 32)
% 95% CI % 95% CI % 95% CI % 95% CI % 95% CI % 95% CI % 95% CI % 95% CI % 95% CI % 95% CI
Concordancea at both visits 89.8 82.1, 97.5 92.4 86.0, 98.8 74.6 63.4, 85.6 71.9 56.2, 87.4 83.8 78.9, 88.7 84.7 76.4, 93.0 80.3 70.7, 89.8 80.0 70.6, 89.3 79.2 69.7, 88.5 81.1 76.5, 85.7
Underreportingb
    At 1 visit onlyc 10.2 2.5, 17.8 7.6 1.2, 13.9 23.7 12.8, 34.5 15.6 3.0, 28.2 13.9 9.3, 18.5 6.9 1.1, 12.8 10.6 3.2, 18.0 11.4 4.0, 18.8 13.9 5.9, 21.8 10.7 7.1, 14.3
    At both visits 0 0, 0 0 0, 0 1.7 0, 5.0 6.3 0, 14.6 1.4 0, 2.9 4.2 0, 8.8 6.1 0.3, 11.8 8.6 2.0, 15.1 5.6 0.3, 10.8 6.1 3.3, 8.9
    Subtotal 10.2 2.5, 17.8 7.6 1.2, 13.9 25.4 14.3, 36.5 21.9 7.6, 36.1 15.3 10.5, 20.1 11.1 3.9, 18.3 16.7 7.7, 25.6 20.0 10.6, 29.3 19.4 10.3, 28.5 16.8 12.4, 21.2
Underdetectiond
    At 1 visit onlyc 0 0, 0 0 0, 0 0 0, 0 6.3 0, 14.6 0.9 0, 2.2 4.2 0, 8.8 0 0, 0 0 0, 0 0 0, 0 1.1 0, 2.3
    At both visits 0 0, 0 0 0, 0 0 0, 0 0 0, 0 0 0 0 0, 0 1.5 0, 4.5 0 0, 0 0 0, 0 0.4 0, 1.1
    Subtotal 0 0, 0 0 0, 0 0 0, 0 6.3 0, 14.6 0.9 0, 2.2 4.2 0, 8.8 1.5 0, 4.5 0 0, 0 0 0, 0 1.4 0, 2.8
Mixed findingse 0 0, 0 0 0, 0 0 0, 0 0 0, 0 0 0 0 0, 0 1.5 0, 4.5 0 0, 0 1.4 0, 4.1 0.7 0, 1.7

Abbreviation: CI, confidence interval.

a

Detection of urinary acetaminophen and/or ibuprofen metabolites matched with self-reported use of acetaminophen and/or ibuprofen.

b

Detection of urinary acetaminophen and/or ibuprofen metabolites but no reported use of acetaminophen and/or ibuprofen.

c

Indicates concordance for the other visit.

d

Reported use of acetaminophen and/or ibuprofen but no detection of urinary acetaminophen and/or ibuprofen metabolites.

e

Underdetection of urinary acetaminophen and/or ibuprofen metabolites at one visit and underreporting of acetaminophen and/or ibuprofen use at the other visit.